INTERVIEWS

Type 1 diabetes patient Reny Partain and diabetes educator Amy Folker highlight the benefits of the recent advancements in diabetes management, as well as share both clinical and first-hand experience for those living with the condition.

Returning guest Jennifer Flynn discusses the lawsuits and action from nursing boards a nurse could face with wrongful delegation, the risks delegating to non-nurse colleagues can carry, real world case studies about wrongful delegation claims, and how as the nursing shortage continues to play out, this can become a problem.

The year 2017 is one of the deadliest flu season for the past two decades. As we enter another flu season, the need for fast and accurate flu testing is more important than ever. Getting a speedy diagnosis and starting treatment within 48 hours can help you bounce back faster. Here’s Dr. Douglas L. Ambler and Dr. Norman Moore with some tips for navigating this flu season.

Dr. Maria B. Schiavone (gynecologic oncologist) and Deyka Torres (cervical cancer survivor) bring awareness to encourage all to get screened for cancer and the importance of early detection.

Dr. Carol Satler discusses the recent (Nov 2018) FDA approval of Gamifant® (emapalumab-lzsg), the first and only treatment indicated for primary hemophagocytic lymphohistiocytosis (HLH). Gamifant®is a product of Sobi, an international bio-pharmaceutical company dedicated to rare diseases.

CEO of Updox CRM, Michael Morgan discusses why healthcare providers have to offer consumers a choice beyond portals, why a secure SMS text solution better reaches patients where they are – on their mobile phones (without the need for an app), and how providers can stop playing phone tag and better engage patients with HIPAA-compliant texting for appointments, scheduling, treatment and more.

Dr. Shankar Musunuri, Ph.D., MBA, is Chairman of the Board, CEO and Co-founder of Ocugen, Inc., discusses the Company’s lead clinical candidate (OCU300) that is currently in Phase 3 for patients with ocular graft versus host disease (oGVHD) and is the first and only therapeutic with orphan drug designation for oGVHD, and the Company’s second lead candidate (OCU310) which is also in Phase 3 for patients with dry eye disease.

CEO of Neem Biotech, Dr. Graham Dixon discusses the presentations at the American Society for Microbiology (ASM) Conference on Biofilms and the North American Cystic Fibrosis (NACF) Conference on a new way to enhance antibiotic effectiveness by reducing biofilms and bacterial virulence more broadly for the development of novel antimicrobial treatments for infections in chronic wounds and chronic respiratory infections including cystic fibrosis.

To build awareness for what the holidays can be like for people with chronic diseases (like MS), Erin Boyt talked about the unique challenges the season can bring.

Erin is a 43-year-old woman who was diagnosed with MS at age 27; she is  heavily involved in the development of GatherMS in her local community (Atlanta, GA) and is passionate about patient education and resources; she volunteers at her local MS center to help support and inform other patients who are newly diagnosed.

Elizabeth Buckle discusses the interoperability questions healthcare organizations should ask before choosing a new EHR for 2019. Recently, Deloitte surveyed 624 primary care and specialty physicians on their attitudes toward EHRs and found that interoperability is their top concern with 62 percent of those surveyed saying they’d like their current system to be more interoperable.